Amarin(AMRN) Stock Price Today | Quotes & News

US Stock MarketDetailed Quotes

AMRN Amarin

Watchlist

0.4026
-0.0200-4.73%

Close Apr 4 16:00 ET

0.4000
-0.0026-0.65%

Post 20:01 ET

166.75MMarket Cap-2.01P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Amarin Highlights Recent Data Presented At ACC.25 Evaluating Mechanistic Effects Of Eicosapentaenoic Acid In Lp(a)-Enriched Plasma And In Combination With GLP-1 Agonist
BenzingaMar 31 08:19 ET
Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms
Seeking AlphaMar 29 11:38 ET
Top Small-cap Value Stocks According to SA Quant
Seeking AlphaMar 24 11:48 ET
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
MT NewswiresMar 24 11:10 ET
Sector Update: Health Care Stocks Mixed Late Afternoon
MT NewswiresMar 19 16:01 ET
Amarin Shareholders Calls for Strategic Review
MT NewswiresMar 19 13:27 ET

Comments

Teddy123

Mar 13 09:59

ARIS MINING REPORTS RECORD Q4 2024 FINANCIAL RESULTS WITH STRONG EBITDA GROWTH AND ANNOUNCES 25% CAPACITY EXPANSION AT MARMATO

$Amarin (AMRN.US)$
Aris Mining Hits Record 57,364 oz Gold Production, Plans 25% Capacity Boost at Marmato

Teddy123

Mar 12 19:18

Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action

$Amarin (AMRN.US)$
Amarin's Global Expansion Bright Spot in Q4 Results as Company Announces Major Stock Restructuring

Teddy123

Feb 27 22:03

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol

$Amarin (AMRN.US)$
Can This Cardiovascular Drug Work Where Others Fall Short? New REDUCE-IT Data Reveals 34% Event Reduction

Jaguar8

Feb 27 22:01

NEWS

$Amarin (AMRN.US)$
Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering
Thursday, 27th February at 9:00 am
-- Peer-Reviewed Paper Indicates Icosapent Ethyl (IPE) Reduced Composite Cardiovascular Endpoint Events Regardless of Baseline LDL-C Levels; Significantly Reduced Events by 34% Among Patients with Very Well-Controlled Low-Density Lipo...

Tonyco

Dec 17, 2024 06:03

$Amarin (AMRN.US)$
undervalued, oversold
C&E: 156M ST Debt: 9.5M, LT Debt: 8.88M CR: 3.2 QR: 2.08 FCF: -18M
The risk of dilution is low for now. However, cash burn is problematic. Expanded to Euro markets w/2039 patent expiry

AMRN Amarin

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Trump's comeback to the Office

Discussing